QBFM
SCLN

QS Batterymarch Financial Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

QS Batterymarch Financial Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5.14M Sell
745,514
-75,980
-9% -$455K 0.14% 230
2014
Q2 		$4.32M Sell
821,494
-89,350
-10% -$435K 0.11% 303
2014
Q1 		$4.14M Buy
910,844
+133,337
+17% +$644K 0.09% 341
2013
Q4 		$3.92M Sell
777,507
-5,810
-0.7% -$28K 0.08% 363
2013
Q3 		$3.97M Hold
783,317
– – 0.09% 348
2013
Q2 		$3.89M Buy
+783,317
New +$3.73M 0.07% 388

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

QS Batterymarch Financial Management's SCLN Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Sciclone Pharmaceuticals Inc (SCLN) stake by 9.2% in Q3 2014, selling an estimated $455K and leaving 745,514 shares worth $5.14M. The position accounts for 0.14% of the portfolio, ranked #230.

QS Batterymarch Financial Management first reported a position in SCLN in Q2 2013 and has held it in 6 quarters since. 116 funds tracked by Wall St. Rank hold SCLN as of Q3 2014.

  • QS Batterymarch Financial Management held 745,514 shares of Sciclone Pharmaceuticals Inc worth $5.14M as of Q3 2014.
  • QS Batterymarch Financial Management sold 75,980 Sciclone Pharmaceuticals Inc shares in Q3 2014, an estimated $455K.
  • Sciclone Pharmaceuticals Inc made up 0.14% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #230 holding.
  • QS Batterymarch Financial Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and has held it in 6 quarters since.
  • 116 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.